Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ...

HengHong Technology, a holding company incorporated in the Cayman Islands, filed for a 2 million-share initial public offering, saying it intends to apply to list on the Nasdaq Capital Market under ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

The Wasatch Global Value Fund—Investor Class returned -5.78% in the fourth quarter of 2024, underperforming the MSCI AC (All Country) World Value Index, which lost -4.71%.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...